NCT03840031

Brief Summary

To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Orange Fleshed Sweet Potato (OFSP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron OFSP variety and a normal market level OFSP variety. The study is conducted in Malawian women of reproductive age with marginal iron status.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 25, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2019

Completed
Last Updated

November 25, 2019

Status Verified

November 1, 2019

Enrollment Period

1 month

First QC Date

February 11, 2019

Last Update Submit

November 21, 2019

Conditions

Keywords

BiofortificationOrange fleshed sweet potatoStable isotope studies

Outcome Measures

Primary Outcomes (2)

  • Fractional iron absorption from both Orange Fleshed Sweet Potato varieties

    Proportion of stable isotope administered with test meals that has been incorporate into erythrocytes 14 days after completion of specific test meal feeding period

    Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.

  • Total iron absorption from both Orange Fleshed Sweet Potato varieties

    Amount of iron absorbed (mg) from the labelled test meals

    Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.

Secondary Outcomes (2)

  • Concentration of plasma ferritin level

    screening (-1), baseline (day 1), last test meal consumption (day 26) and 14 days after last test meal consumption (day 40)

  • Concentration of plasma CRP level

    screening (-1), baseline (day 1), last test meal consumption (day 26) and 14 days after last test meal consumption (day 40)

Study Arms (2)

Orange Fleshed Sweet Potato High Iron

EXPERIMENTAL

Meal sequence B, OFSP High Fe

Other: High Fe OFSP meal labelled with Fe-58

Orange Fleshed Sweet Potato Control

ACTIVE COMPARATOR

Meal sequence A, OFSP control

Other: Control OFSP meal labelled with Fe-57

Interventions

400 gram steamed, mashed OFSP high Fe with 0.33 mg FeSO4-58 daily for 10 days

Orange Fleshed Sweet Potato High Iron

400 gram steamed, mashed OFSP control with 0.33 mg FeSO5-57 daily for 10 days

Orange Fleshed Sweet Potato Control

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBased on health passport or birth certificate.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Woman aged 18-35 years old
  • low/marginal iron status respectively evidenced by one of the following criteria: PF ≤ 25 µg/L
  • Normal BMI for age (18.5-25.0 kg/m2)
  • Weight less than 65 kg. A maximum weight limitation is needed since the stable isotope portions are based on body weight. We want to give equal amounts of stable isotopes to each study participant and therefore need to standardize body weight.
  • Living in a study radius of 30 km from the meal distribution/ health centre side
  • Willing and able to commute to the set meal distribution/ health centre side
  • Able to understand and to sign\* written concept prior to trial entry
  • Informed consent signed \* Signing of informed consent by either autograph or finger print.

You may not qualify if:

  • Severe anaemia Hb \<80 g/l
  • High infection rate based on CRP \> 5 mg/L
  • Any known chronic diseases
  • Relevant digestive (intestinal, gastric, hepatic or pancreatic), renal, metabolic disease, as determined by the screening visit and by self-report from the subjects.
  • Diagnosed food allergy.
  • Pregnancy (urine test during screening
  • Lactation.
  • History of cancer within the past year, from self-report by the woman or as obtained from her health passport
  • Any medication or supplement which may impact erythrocytes, Hb or haematocrit (to the opinion of the investigator).
  • Iron supplementation therapy or perfusion in the last three months
  • Significant blood losses over the past 6 months (i.e. trauma, major surgery, blood donation or other cause influencing blood volume to be investigated by the PI)
  • Have a high alcohol consumption (more than 2 drinks/day).
  • Consumption of illicit drugs based on reported use (based on anamnesis only).
  • Subject having a hierarchical link with the investigator or co-investigators.
  • Fever (body temperature \>37.5 °C), on day 1 of the feeding scheme
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Training and Research Unit of Excellence, University of Malawi

Zomba, Malawi

Location

Swiss Federal Institute of Technology, Laboratory of Human Nutrition

Zurich, Canton of Zurich, 8092, Switzerland

Location

Related Publications (1)

  • Jongstra R, Mwangi MN, Burgos G, Zeder C, Low JW, Mzembe G, Liria R, Penny M, Andrade MI, Fairweather-Tait S, Zum Felde T, Campos H, Phiri KS, Zimmermann MB, Wegmuller R. Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women. J Nutr. 2020 Dec 10;150(12):3094-3102. doi: 10.1093/jn/nxaa267.

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Michael Zimmermann, Prof.

    Swiss Federal Institute of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participant is blinded, meal option A --\> B or B --\> A based on investigator randomisation.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Each woman consumes both Orange Fleshed Sweet Potato varieties
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2019

First Posted

February 15, 2019

Study Start

March 25, 2019

Primary Completion

May 3, 2019

Study Completion

May 3, 2019

Last Updated

November 25, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations